Axogen, Inc. (AXGN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Axogen, Inc. (AXGN)
Go deeper and ask any question about AXGN
Company Performance
Current Price
as of Sep 13, 2024$13.79
P/E Ratio
N/A
Market Cap
$604.41M
Description
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Metrics
Overview
- HQAlachua, FL
- SectorHealth Technology
- IndustryMedical Specialties
- TickerAXGN
- Price$13.79+1.62%
Trading Information
- Market Cap$604.41M
- Float94.30%
- Average Daily Volume (1m)376,600
- Average Daily Volume (3m)433,791
- EPS-$0.38
Company
- Revenue$173.48M
- Rev Growth (1yr)25.57%
- Net Income-$1.92M
- Gross Margin73.77%
- EBITDA Margin3.41%
- EBITDA$1.63M
- EV$358.38M
- EV/Revenue2.07
- P/EN/A
- P/S3.47
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset